Yannick Le Bris

19PUBLICATIONS
105CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Molecular targetsMedical biotechnology diagnostics (incl. biosensors)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Feb 19, 2026
CD40/PI3K/FOXO1 axis rewiring drives microenvironment-dependent BIM silencing to sustain lymphoma growth and survival.

Candice Madiot, Céline Bellanger, Christelle Dousset

|Sep 30, 2025
GPVI as a Potential New Biomarker for Myelofibrosis Diagnosis.

Xavier Hittinger, Yannick Le Bris, Yacine El Aiba

|May 15, 2025
Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX.

Vincent Jachiet, Olivier Kosmider, Maxime Beydon

|Apr 01, 2025
Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric study.

Lucile Bussot, Stéphanie Poulain, Morgane Nudel Ortmans

|Sep 14, 2024
Deep Learning-Based Blood Abnormalities Detection as a Tool for VEXAS Syndrome Screening.

Cédric De Almeida Braga, Maxence Bauvais, Pierre Sujobert

|Jan 02, 2024
Phase I study of zoledronic acid combined with escalated doses of interleukine-2 for early in vivo generation of Vγ9Vδ2 T-cells after haploidentical stem cell transplant with posttransplant cyclophosphamide.

Maxime Jullien, Thierry Guillaume, Amandine Le Bourgeois

Pageof 4

Frequent Collaborators

6 joint publications

Benoît Tessoulin

5 joint publications

Marie-Christine Béné

4 joint publications

Marion Eveillard

3 joint publications

David Chiron